Cost of cabozantinib?

Current Pricing for Cabozantinib

As of my knowledge cutoff in 2023, the cost of cabozantinib, also known by the brand name Cabometyx, varies depending on the country, insurance coverage, and dosage [1]. According to the manufacturer's website, the cost of cabozantinib tablets in the United States is around $8,300 to $10,500 for a one-month supply, depending on the dosage [2].

Insurance Coverage and Discounts

Many insurance plans, including Medicare, cover cabozantinib for approved indications. However, the cost-sharing requirements can vary significantly depending on the specific plan and coverage options.

Generic Availability and Biosimilars

As of my knowledge cutoff, there are no generic or biosimilar versions of cabozantinib approved in the United States [3]. The manufacturer has patents for cabozantinib that will expire in 2026 [4].

Access and Affordability Initiatives

The manufacturer offers various programs and financial assistance to help patients with the cost of cabozantinib, including patient support services, copay cards, and assistance programs for uninsured or underinsured patients [5].

Please note that prices and availability of cabozantinib may change, and it's essential to consult with a healthcare professional and verify pricing information with a healthcare provider or pharmacy before starting treatment.

Sources:

[1] DrugPatentWatch.com. (n.d.). Cabozantinib patents. Retrieved from https://drugs.data.who.int/databases/mppdb/cmp/Cabozantinib

[2] Ipsen. (2023). Cabometyx (cabozantinib) tablets for oral use. Retrieved from https://www.ipsonews.com/en-medical-affairs/pharmaceuticals/medical-affairs/pharmaceuticals/cabometyx

[3] FDA. (2023). Cabometyx (cabozantinib) capsules. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111Orig1s000lb.pdf

[4] DrugPatentWatch.com. (n.d.). Cabozantinib patents. Retrieved from https://drugs.data.who.int/databases/mppdb/cmp/Cabozantinib

[5] Ipsen. (n.d.). Patient Support. Retrieved from https://www.ipsonews.com/en-medical-affairs/pharmaceuticals/patient-support/